LOGO
LOGO

Quick Facts

Glanbia H1 Profit, Revenue Drop; Starts EUR 50 Mln Share Buyback

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Glanbia plc (GLB.L), a nutrition company, Wednesday reported profit before taxation of $169.7 million for the first half, lower than $214 million in the same period a year ago.

Excluding items, adjusted profit before taxation increased to $180.9 million from $158.1 million last year.

Operating profit declined to $176.4 million from $214.5 million on decreased revenue.

Adjusted operating profit rose to 187.6 million from $158.6 million last year.

Net profit was $143.3 million or 54.71 cents per share, down from $193.4 million or 70.91 cents per share a year ago.

Adjusted profit increased to $152.5 million or 68.20 cents per share from $136.9 million or 60.78 cents per share last year.

Revenue for the period dropped to $1.816 billion from reported revenue of $2.771 billion and adjusted revenue of 1.836 billion in the previous year.

The Board has recommended an interim dividend of 15.64 euro cents per share, 10 percent up from 14.22 euro cents per share last year, to be paid on October 4 to shareholders of record on August 23.

Looking ahead, the company has reaffirmed its full-year adjusted EPS growth outlook in the range of 5 percent to 8 percent.

Additionally, Glanbia said the remaining 50 million euros share buyback, out of 100 million euros announced in February this year, will commence today.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

RELATED NEWS
Latest Updates on COVID-19